Literature DB >> 1663573

Rapid diagnosis of cytomegalovirus infections by direct immunoperoxidase staining with human monoclonal antibody against an immediate-early antigen.

Y Eizuru1, T Minematsu, Y Minamishima, K Ebihara, K Takahashi, K Tamura, K Hosoda, Y Masuho.   

Abstract

Direct immunoperoxidase technique using a horseradish peroxidase (HRP)-conjugated Fab' fragment of human monoclonal antibody (humab C7), designated HRP-C7, was evaluated as a rapid diagnosis of cytomegalovirus (CMV) infection. A total of 138 clinical specimens consisting of 124 urine samples and 14 oral swabs were examined for CMV by the direct HRP-C7 staining in comparison with conventional virus isolation. The number of CMV-positive samples by each method was 40 (29.0%) for the former and 37 (26.8%) for the latter, respectively. By HRP-C7 staining, CMV was identifiable within 24 hr after inoculation. By conventional isolation method, an average of 10.3 days had passed before cytopathic effect characteristic of CMV appeared in the cell culture. Some false-positive and false-negative cases were discussed in relation to toxicity of urine samples, storage of the samples, and amount of CMV in the sample. The sensitivity and specificity of HRP-C7 method against conventional isolation method were 89.2% and 93.1%, respectively. Thus, HRP-C7 staining is useful for a rapid diagnosis of CMV infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663573     DOI: 10.1111/j.1348-0421.1991.tb01623.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

1.  Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.

Authors:  Hideo Tanaka; Shizuka Nakashima; Miyuki Usuda
Journal:  Int J Hematol       Date:  2012-07-06       Impact factor: 2.490

2.  Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.

Authors:  Tadayuki Kou; Hiroshi Nakase; Hiroyuki Tamaki; Toyoichiro Kudo; Akiyoshi Nishio; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

Review 3.  Large granular lymphocytosis during dasatinib therapy.

Authors:  Zhi-Yuan Qiu; Wei Xu; Jian-Yong Li
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

4.  Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Katsuto Takenaka; Koji Nagafuji; Ken Takase; Tomohiko Kamimura; Yasuo Mori; Yoshikiyo Ito; Yukiko Nishi; Hideho Henzan; Koji Kato; Naoki Harada; Tetsuya Eto; Toshihiro Miyamoto; Takanori Teshima; Koichi Akashi
Journal:  Int J Hematol       Date:  2012-05-01       Impact factor: 2.490

5.  Opportunistic infection in patients with acute liver failure.

Authors:  Makoto Arai; Tatsuo Kanda; Shin Yasui; Keiichi Fujiwara; Fumio Imazeki; Akira Watanabe; Takeyuki Sato; Shigeto Oda; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-01-24       Impact factor: 6.047

6.  Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection.

Authors:  Eui Ho Kim; Kazuhiro Ikegame; Manabu Kawakami; Sumiyuki Nishida; Tatsuya Fujioka; Yuki Taniguchi; Tomoki Masuda; Yoshihiro Oka; Ichiro Kawase; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

7.  Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.

Authors:  Kazuhiro Ikegame; Katsuji Kaida; Keiko Fukunaga; Yuko Osugi; Kyoko Yoshihara; Satoshi Yoshihara; Shinichi Ishii; Satoshi Fujino; Takaya Yamashita; Azusa Mayumi; Satoshi Maruyama; Masahiro Teramoto; Takayuki Inoue; Masaya Okada; Hiroya Tamaki; Hiroyasu Ogawa; Yosihiro Fujimori
Journal:  Bone Marrow Transplant       Date:  2020-06-20       Impact factor: 5.483

8.  Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation.

Authors:  Kazuya Sato; Sho Igarashi; Nodoka Tsukada; Junki Inamura; Masayo Yamamoto; Motohiro Shindo; Kentaro Moriichi; Yusuke Mizukami; Mikihiro Fujiya; Yoshihiro Torimoto
Journal:  BMC Cancer       Date:  2022-09-01       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.